Trial Profile
A Phase 3, Multicenter, Randomized, Blinded, Controlled Study of NV-101 for Efficacy, Pharmacodynamics and Safety in Dental Patients Undergoing Maxillary Procedures
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 May 2014
Price :
$35
*
At a glance
- Drugs Phentolamine (Primary)
- Indications Regional anaesthesia
- Focus Therapeutic Use
- Sponsors Novalar Pharmaceuticals
- 14 May 2014 New trial record